Andreas Schaaf
Director Técnico/Científico/I+D en Eleva GmbH .
Origen de la red de primer grado Andreas Schaaf.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Eleva GmbH
Eleva GmbH BiotechnologyHealth Technology Eleva GmbH develops biotechnology products and services. It offers Moss-aGal, Moss-GBA, Moss-FH, contract development and production, developmental pipeline, and technology transfer. The company was founded by Ralf Reski and Gunther Neuhaus in 1999 and is headquartered in Heilbronn, Germany.
9
| Holding Company | Biotechnology | 9 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Andreas Schaaf a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
DEUTSCHE BANK AG | Regional Banks | Corporate Officer/Principal | |
ABBVIE INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Pennsylvania | College/University | Masters Business Admin | |
University of Cambridge | College/University | Graduate Degree | |
Technische Universität München | College/University | Doctorate Degree | |
University of Hamburg | College/University | Doctorate Degree | |
Ruprecht-Karls-Universität Heidelberg | College/University | Corporate Officer/Principal | |
Universität des Saarlandes | College/University | Doctorate Degree | |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Chief Operating Officer | |
Southmore Capital Pty Ltd.
Southmore Capital Pty Ltd. Investment ManagersFinance Southmore Capital Pty Ltd (Southmore) is a venture capital firm is founded in 2006 by Dr. Jurgen Michaelis. The firm is headquartered in Adelaide. | Investment Managers | Investment Committee Member | |
Isogenica Ltd.
Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Isogenica Ltd. provides research and development services in the fields of new peptide, antibody and other polypeptide drug candidates. It offers llamdA System, Xab System and 4D Fab System. The company was founded by Kevin Fitzgerald in 2000 and is headquartered in Little Chesterford, the United Kingdom. | Miscellaneous Commercial Services | Chairman | |
baseclick GmbH
baseclick GmbH Miscellaneous Commercial ServicesCommercial Services baseclick GmbH provides alkyne-modified nucleosides for chemical and enzymatic DNA synthesis. Its products include phosphoramidites, triphosphates, non-fluorescent azides, non-fluorescent alkynes, fluorescent dye azides and fluorescent dye alkynes. The company was founded by Thomas Carell in April 2008 and is headquartered in Neuried, Germany. | Miscellaneous Commercial Services | Chief Executive Officer | |
KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chairman | |
Allecra Therapeutics GmbH
Allecra Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Allecra Therapeutics GmbH focuses on the development of novel treatments to combat multi drug-resistant bacterial infections. The firm serves the bio and pharmaceutical industry. The company was founded by Nicholas Benedict and Stuart Shapiro in 2013 and is headquartered in Weil am Rhein, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
University of Edinburgh Law School | College/University | Undergraduate Degree | |
Cantab Research Ltd.
Cantab Research Ltd. Packaged SoftwareTechnology Services Cantab Research Ltd. provides speech and automatic speech recognition technology. It offers batch virtualized ASR, batch containerized ASR, real time virtual appliance, private cloud and elastic ASR, and cloud transcription services. The company was founded by Anthony J. Robinson in 2009 and is headquartered in Cambridge, the United Kingdom. | Packaged Software | Chief Executive Officer | |
Atriva Therapeutics GmbH
Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany. | Biotechnology | Corporate Officer/Principal | |
BIOCURE TECHNOLOGY INC. | Biotechnology | President | |
Sapreme Technologies BV
Sapreme Technologies BV BiotechnologyHealth Technology Sapreme Technologies BV operates as a biotech company that develops a platform technology to enable cytosolic delivery of macromolecule therapeutics. The company was founded by Ruben Postel in 2016 and is headquartered in Utrecht, the Netherlands. | Biotechnology | Chairman | |
Ciliatech Therapeutics AG
Ciliatech Therapeutics AG Pharmaceuticals: MajorHealth Technology Ciliatech Therapeutics AG is a Swiss company that focuses on researching, developing, producing, and distributing pharmaceutical and diagnostic products. | Pharmaceuticals: Major | Chief Executive Officer | |
Selvedge Innovation LLP
Selvedge Innovation LLP Investment ManagersFinance Selvedge Innovation LLP (Selvedge Venture) is a venture capital firm founded in 2019 by Alasdair Thong and Robert Thong. The firm is headquartered in London, United Kingdom. | Investment Managers | Consultant / Advisor | |
Sanome Ltd
Sanome Ltd Miscellaneous Commercial ServicesCommercial Services Sanome Ltd is a British biotechnology company founded in 2021. The company is based in Cambridge, UK and has subsidiaries in United Kingdom. Sanome engages in research and development of biotechnology. | Miscellaneous Commercial Services | Chief Executive Officer | |
Syntensor Ltd
Syntensor Ltd Miscellaneous Commercial ServicesCommercial Services Syntensor Ltd is a British company that develops machine learning methods combined with first-principles thinking in biology to assist drug developers, clinicians, and physicians in answering fundamental questions. The company was founded by Clayton Rabideau and Rosie Higgins, with Clayton Rabideau serving as CEO since incorporation. | Miscellaneous Commercial Services | Consultant / Advisor | |
Curegenius | Founder | ||
Global Innovation Path | Founder | ||
Medraxa Therapeutics GmbH | Chief Executive Officer | ||
BC Biomed Consulting GmbH | Chief Executive Officer |
Estadísticas
Internacional
Alemania | 13 |
Reino Unido | 10 |
Estados Unidos | 8 |
Noruega | 2 |
Australia | 2 |
Sectorial
Health Technology | 12 |
Consumer Services | 8 |
Commercial Services | 7 |
Finance | 6 |
Utilities | 2 |
Operativa
Chief Executive Officer | 11 |
Corporate Officer/Principal | 9 |
Chairman | 4 |
Founder | 4 |
Director of Finance/CFO | 4 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Andreas Schaaf
- Conexiones Empresas